Trump's Plan to Lower Drug Prices
Digest more
Merck KGaA reduced its outlook for sales and profit growth this year, citing the impact of a weak US dollar and uncertainty around tariffs.
Analysts are still crunching the numbers on the impact of President Donald Trump's executive order from Monday on drug pricing. HSBC analyst Rajesh Kumar says a 20% price cut in government channels could result in 15% operating profit cuts in the industry.
Merck & Co.‘s planned debut this fall of an injectable form of its breakthrough cancer treatment Keytruda will simplify care, expand access, and save more lives, the company says. But by shifting patients to a version protected by newer patents,
Global pharmaceutical shares are slumping Monday after President Donald Trump said he is looking to slash the price of prescription drugs in the U.S. by as much as 80%.
Shares of U.S. drugmakers rebounded on Monday after an initial selloff as analysts said that President Donald Trump's sweeping executive order to slash prescription drug prices would be difficult to implement and face legal challenges.
Patients will likely eventually see higher prices and drug shortages under President Trump's plan to assess tariffs on prescription drug imports.
9h
President Donald Trump signed an executive order this week setting a 30-day deadline for drugmakers to electively lower prices in the U.S. or face new limits on what the government will pay
US court shuts down AstraZeneca's challenge to Medicare drug price ... on the impact of U.S. tariffs, tax policy would be a more effective way to influence U.S. manufacturing. Merck to invest ...
Feedback